Blood test could help kids avoid harmful steroid side effects after transplant

NCT ID NCT05090384

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a blood test (GVHD biomarkers) can help doctors safely reduce steroid doses in children with graft-versus-host disease (GVHD) after a bone marrow transplant. Fifty children with newly diagnosed GVHD received prednisone, and those with low biomarker levels and good clinical response had their steroids tapered quickly. The goal was to see if this approach could maintain treatment success while reducing short- and long-term steroid side effects like infections, bone damage, and growth problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Prednisone
What this could lead to
If successful, this approach could reduce steroid side effects in children with GVHD while maintaining treatment effectiveness.
What could go wrong
This is a small Phase 2 trial with only 50 participants, so results may not apply to all children. The biomarker test may not accurately predict who can safely taper steroids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE GRAFT VS HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Children's Hospital Dana Farber Cancer Institute

    Boston, Massachusetts, 02115, United States

  • Children's Healthcare of Atlanta

    Atlanta, Georgia, 30322, United States

  • Children's Hospital of Los Angeles

    Los Angeles, California, 90027, United States

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • Children's National Hospital

    Washington D.C., District of Columbia, 20010, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

  • Medical College of Wisconsin / Children's Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Texas Children's Hospital, Baylor College of Medicine

    Houston, Texas, 77030, United States

  • The Hospital for Sick Children

    Toronto, Ontario, M5S, Canada

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.